Dacomitinib Hydrate-impurities | Pharmaffiliates

Dacomitinib Hydrate

Dacomitinib Hydrate, sold under the brand name Vizimpro, is a medication for the treatment of non-small-cell lung carcinoma. Reference standards of Dacomitinib Hydrate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Dacomitinib Hydrate - API Standards
    [catalogue_number] => PA 04 2980000
    [category_ids] => ,75,78,79,82,
    [chemical_name] => 
    [weight] => 487.96
    [form] => C24H27ClFN5O3
    [cas] => 1042385-75-0
    [pslug] => 1042385-75-0-dacomitinib-hydrate-api-standards-pa042980000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 04 2980000

Dacomitinib Hydrate - API Standards


  • Catalogue No.:PA 04 2980000

  • CAS :

    1042385-75-0

  • Molecular Formula : C24H27ClFN5O3

  • Molecular Weight : 487.96